-+ 0.00%
-+ 0.00%
-+ 0.00%

Scinai Immunotherapeutics changes ADS ratio in move equivalent to 1-for-10 reverse split

PUBT·08/19/2026 13:26:34
Listen to the news
Scinai Immunotherapeutics changes ADS ratio in move equivalent to 1-for-10 reverse split
  • Scinai Immunotherapeutics will change its ADS-to-ordinary share ratio to 1 ADS for 40,000 shares from 1 for 4,000.
  • Move takes effect Aug. 21, 2026, equating to a 1-for-10 reverse split of the ADSs.
  • ADSs to trade on Nasdaq on an adjusted basis under SCNI; new CUSIP 09073Q402.
  • Fractional ADS entitlements to be aggregated and sold; cash proceeds distributed by the depositary bank.
  • Objective is to lift the per-ADS price to help regain compliance with Nasdaq’s $1 minimum bid rule.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scinai Immunotherapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-091445), on August 19, 2026, and is solely responsible for the information contained therein.